Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystinosis | 6 | 2022 | 15 | 1.380 |
Why?
|
| Kidney Transplantation | 3 | 2020 | 574 | 1.240 |
Why?
|
| Fever of Unknown Origin | 2 | 2018 | 45 | 1.170 |
Why?
|
| Exostoses, Multiple Hereditary | 2 | 2019 | 14 | 0.690 |
Why?
|
| Exostoses | 1 | 2019 | 2 | 0.620 |
Why?
|
| Graft Rejection | 2 | 2018 | 566 | 0.560 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 674 | 0.550 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 149 | 0.520 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 313 | 0.520 |
Why?
|
| Kidney Failure, Chronic | 3 | 2018 | 905 | 0.510 |
Why?
|
| Cysteamine | 4 | 2022 | 15 | 0.480 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 748 | 0.480 |
Why?
|
| Hypertension | 2 | 2019 | 1348 | 0.460 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2009 | 17 | 0.320 |
Why?
|
| Mycophenolic Acid | 2 | 2018 | 58 | 0.290 |
Why?
|
| Biopsy | 3 | 2018 | 1298 | 0.290 |
Why?
|
| Bone Marrow | 2 | 2018 | 333 | 0.260 |
Why?
|
| Fanconi Syndrome | 3 | 2022 | 9 | 0.260 |
Why?
|
| Myelolipoma | 1 | 2005 | 3 | 0.250 |
Why?
|
| Adrenocortical Adenoma | 1 | 2005 | 9 | 0.250 |
Why?
|
| Renal Insufficiency | 2 | 2020 | 255 | 0.250 |
Why?
|
| Hemorrhage | 1 | 2009 | 516 | 0.240 |
Why?
|
| Adrenalectomy | 1 | 2005 | 39 | 0.240 |
Why?
|
| Lung Diseases | 1 | 2009 | 404 | 0.240 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 64 | 0.240 |
Why?
|
| Renal Dialysis | 3 | 2018 | 891 | 0.230 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 77 | 0.230 |
Why?
|
| Adolescent | 10 | 2019 | 20557 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 676 | 0.190 |
Why?
|
| Nephrologists | 1 | 2021 | 17 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2019 | 88 | 0.170 |
Why?
|
| Gallbladder | 1 | 2020 | 21 | 0.170 |
Why?
|
| Laparoscopy | 1 | 2005 | 520 | 0.160 |
Why?
|
| Pediatricians | 1 | 2021 | 71 | 0.160 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2020 | 9 | 0.160 |
Why?
|
| Bone Diseases | 1 | 2019 | 45 | 0.150 |
Why?
|
| Antigens, Fungal | 1 | 2018 | 34 | 0.150 |
Why?
|
| Renin | 1 | 2019 | 87 | 0.150 |
Why?
|
| Kidney | 2 | 2020 | 1347 | 0.150 |
Why?
|
| Histoplasma | 1 | 2018 | 37 | 0.150 |
Why?
|
| Amphotericin B | 1 | 2018 | 91 | 0.150 |
Why?
|
| Histoplasmosis | 1 | 2018 | 55 | 0.150 |
Why?
|
| Leukocyte Count | 1 | 2018 | 249 | 0.140 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 132 | 0.140 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 663 | 0.140 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 268 | 0.130 |
Why?
|
| Viral Load | 1 | 2018 | 407 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2019 | 541 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 226 | 0.130 |
Why?
|
| Heterozygote | 1 | 2019 | 729 | 0.130 |
Why?
|
| Humans | 18 | 2022 | 133015 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12963 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 87 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 132 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 174 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2018 | 327 | 0.120 |
Why?
|
| Cystine Depleting Agents | 1 | 2014 | 2 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 168 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 359 | 0.110 |
Why?
|
| Female | 11 | 2020 | 71346 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2018 | 825 | 0.100 |
Why?
|
| Registries | 1 | 2020 | 1584 | 0.100 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2012 | 23 | 0.090 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 84 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1037 | 0.090 |
Why?
|
| Phenotype | 2 | 2019 | 4570 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2012 | 158 | 0.080 |
Why?
|
| Methylprednisolone | 1 | 2009 | 98 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 142 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 789 | 0.070 |
Why?
|
| Craniofacial Abnormalities | 1 | 2010 | 252 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 312 | 0.070 |
Why?
|
| Child | 9 | 2021 | 25830 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2586 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3361 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2185 | 0.060 |
Why?
|
| Infant | 5 | 2020 | 13142 | 0.050 |
Why?
|
| Male | 8 | 2020 | 65312 | 0.050 |
Why?
|
| Hemofiltration | 1 | 2004 | 11 | 0.050 |
Why?
|
| Carbamazepine | 1 | 2004 | 46 | 0.050 |
Why?
|
| Quality of Life | 1 | 2014 | 2156 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 968 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2020 | 14842 | 0.050 |
Why?
|
| Lung | 1 | 2009 | 1563 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2004 | 391 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2022 | 193 | 0.040 |
Why?
|
| Nephrology | 1 | 2021 | 156 | 0.040 |
Why?
|
| Iohexol | 1 | 2017 | 21 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 322 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2022 | 1461 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2017 | 32 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 712 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 6483 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5416 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 79 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 267 | 0.030 |
Why?
|
| Nutritional Status | 1 | 1998 | 326 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 566 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 122 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 390 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 589 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 519 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1731 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 870 | 0.020 |
Why?
|
| Pediatrics | 1 | 2021 | 1216 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 541 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2933 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2014 | 774 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1341 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 31723 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3086 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8531 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3656 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 158 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1306 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2858 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1173 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 379 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2004 | 75 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 6560 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10883 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9966 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3862 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17415 | 0.010 |
Why?
|